- Biotech business founded by top scientists
- >100 million USD funding from top investors
About Our Client
Our client is a biotech start up business founded by top scientists and backed by top tier investors, aiming for IPO in HK/US. The business has an international team spreading across China, US and Europe with strong product pipeline at clinical stage 2/3 in immunology and Oncology and valuation over 500m USD. The IPO timeline will be likely in 12 months' time.
The CFO will lead the IPO process, heavily involved in business strategy and product portfolio planning as well as business development opportunities including license-in and license-out. He/she will work closely with the top management team as well as investors to drive funding and manage investor relations by presenting the business performance and reporting thoroughly. The CFO will manage the finance team and ensure sound risk/compliance processes are in place.
To apply online please click the Apply button below. For a confidential discussion about this role please contact Jane Zhou on +86 21 6062 3066.
The Successful Applicant
The successful applicant ideally comes from investment bank with track record of biotech IPO projects, able to talk with scientists/investors with good understanding of products. Corporate finance experience working for pre IPO businesses will be a big plus. The CFO is required to have strong business acumen, sensitive to numbers with excellent problem solving and leadership skills. Mandarin skills is highly preferred but not a must and location can be flexible in HK/Mainland China/US.
What's on Offer
You will work with a team of top entrepreneurs and top investors from the globe, IPO will be in a short time frame. strong R&D capability and competitive product portfolio. Attractive package including stock scheme will be offered.